The University of Pittsburgh's clinical trial focuses on the innovative application of BCI technology to enhance communication for individuals with severe disabilities, such as ALS, TBI, and cerebral palsy. The market for AAC devices is expanding, driven by increasing awareness and demand for assistive technologies. This study's findings could position the University of Pittsburgh as a leader in the AAC-BCI space, potentially attracting partnerships or funding from healthcare providers and technology developers. Competitive implications include the need to monitor existing AAC solutions and emerging BCI technologies that may enter the market. Diligence considerations should include assessing the scalability of the technology and its integration into existing healthcare frameworks.